VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
SOLV
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
SOLVSolventum Corporation
$90.38$15.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. SOLV
  4. Financial Ratios

Solventum Corporation (SOLV) Financial Ratios

Latest Ratios: P/E Ratio 99.0x · EV/EBITDA 8.3x · ROE 38.9%. (2021–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

SOLV Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Market Cap$15.7B$13.9B$11.5B———
Enterprise Value$19.8B$18.0B$18.7B———
P/E Ratio →98.968.9223.93———
P/S Ratio1.921.671.39———
P/B Ratio3.142.753.88———
P/FCF——14.25———
P/OCF42.4237.649.68———

P/E links to full P/E history page with 30-year chart

SOLV EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021
EV / Revenue—2.172.27———
EV / EBITDA8.326.7611.77———
EV / EBIT9.088.7619.26———
EV / FCF——23.26———

SOLV Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Gross Margin53.5%53.5%55.6%57.3%57.7%60.2%
Operating Margin26.2%26.2%12.6%20.6%20.8%23.0%
Net Profit Margin18.7%18.7%5.8%16.4%16.5%17.9%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021
ROE38.9%38.9%6.6%11.5%11.3%12.1%
ROA10.8%10.8%3.4%9.8%9.7%10.4%
ROIC16.9%16.9%5.2%8.0%10.6%11.7%
ROCE19.0%19.0%8.6%13.8%13.6%14.8%

SOLV Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Debt / Equity1.001.002.710.710.010.01
Debt / EBITDA1.891.895.033.690.040.05
Net Debt / Equity—0.822.450.700.000.00
Net Debt / EBITDA1.561.564.563.600.010.01
Debt / FCF——9.004.990.020.01
Interest Coverage5.945.942.65———

SOLV Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Current Ratio1.231.231.201.461.701.56
Quick Ratio0.890.890.840.961.040.98
Cash Ratio0.280.280.280.110.050.06
Asset Turnover—0.580.570.590.600.58
Inventory Turnover3.633.633.794.093.934.00
Days Sales Outstanding—45.3354.3558.4752.5752.58

SOLV Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Dividend Yield——————
Payout Ratio——————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Earnings Yield1.0%11.2%4.2%———
FCF Yield——7.0%———
Buyback Yield0.0%0.0%0.0%———
Total Shareholder Yield0.0%0.0%0.0%———
Shares Outstanding—$175M$174M$173M$172M$172M

Key Metrics

Growth RegimeStable
ProfitabilityModerate
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Volatile cash conversion and thin liquidity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Trailing Multiples Overstate Earnings Power

Based on Solventum's reported figures, a trailing P/E near 99 against a forward P/E of 12.6 suggests trailing earnings are depressed or distorted, while EV/EBITDA of 8.3 times sits at a moderate level for a company with flat revenue growth of roughly 0.9 percent.

The gap between trailing and forward P/E implies the market is looking through recent earnings volatility, including the Q3 2026 EPS shortfall, toward a normalized earnings base. The EV/EBITDA multiple of 8.3 times appears more reasonable than the P/E, and investors should monitor whether forward EBITDA estimates hold given the ERP transition. Without a PEG ratio or free cash flow multiple available, valuation conclusions rest mainly on earnings forecasts that have not yet been validated by sustained organic growth.

Margin Stability Masks Quarterly Earnings Noise

Gross margin has held between 49.3 and 58.2 percent across recent quarters, while operating margin swung from 3.5 percent to 84.0 percent, indicating that reported operating profitability is heavily affected by non-recurring items rather than core operations.

The consistency of gross margin suggests pricing discipline and a stable product mix, which supports the view that underlying manufacturing economics are intact. The operating margin spikes, including the 84.0 percent print in Q4 2025, appear inconsistent with the underlying business and may reflect separation-related or other one-time items that warrant adjustment before use as an earnings power measure. Net margin of negative 0.6 percent in Q3 2026 against 60.4 percent in Q3 2025 reinforces that headline profitability is unreliable as a standalone indicator.

Deleveraging Progress Tied to Equity Rebuilding

Debt-to-equity has fallen from 2.90 in mid-2024 to 1.00 in late 2025, but debt-to-EBITDA of 92.5 times in Q3 2026 and interest coverage of 0.84 times in the same quarter suggest debt service has become strained on a quarterly basis.

The improvement in debt-to-equity appears driven more by equity recovery than by sustained debt reduction, so the leverage picture depends heavily on balance sheet presentation. Interest coverage falling below 1.0 times in Q3 2026 is a notable warning sign, although the swing from 18.0 times in Q3 2025 indicates the metric is sensitive to quarterly earnings timing. Investors should treat the debt-to-EBITDA reading as an indicator that quarterly EBITDA is currently too thin to comfortably service the roughly $5.3 billion debt load.

Working Capital Cushion Narrowing Under Pressure

The current ratio declined from 1.50 in Q3 2025 to 1.03 in Q3 2026, while the quick ratio fell from 1.14 to 0.72, suggesting the company's short-term liquidity buffer has thinned materially over the past year.

A quick ratio below 1.0 means the company relies on inventory conversion or ongoing receivables collection to meet current obligations, which appears less comfortable under a stress scenario. The cash decline referenced in the balance sheet data reinforces this view, as limited cash reserves leave less room to absorb a sudden earnings shortfall. The cash conversion cycle of 99 days in Q3 2026, up from 85 days a year earlier, suggests working capital is absorbing more cash and may warrant monitoring of receivables and inventory trends.

Cash Conversion Cycle Lengthening Steadily

Based on Solventum's reported figures, the cash conversion cycle expanded from 77 days in Q2 2025 to 99 days in Q3 2026, driven by rising days inventory outstanding that reached 111 days, which suggests slower inventory turnover is tying up working capital.

Days inventory outstanding climbing to 111 days in Q3 2026 from 84 days in Q2 2025 indicates inventory is moving more slowly, which may reflect demand softness or supply chain adjustments tied to the ERP transition. Days sales outstanding has stayed relatively stable near 47 to 67 days, so the deterioration appears concentrated in inventory rather than collections. The asset turnover ratio of roughly 0.14 to 0.16 is consistent with a capital-intensive, asset-heavy base, and the lengthening cycle appears to be eroding the working capital efficiency that supported earlier cash generation.

Cash Quality Obscured by Working Capital Timing

Based on Solventum's reported figures, the swing in working capital from negative $360M in Q1 2026 to positive $459M in Q3 2026 may indicate that headline cash results are driven more by timing than by durable generation, a dependency the ratio profile alone does not resolve.

Trailing P/E near 99 and a 60.4 percent net margin in Q3 2025 both illustrate how a single non-recurring item can dominate ratio readings, so the headline metrics may flatter or penalize the business depending on the quarter chosen. Investors may find that the most commonly misapplied measure here is the trailing P/E, which should be replaced with normalized earnings or forward EBITDA adjusted for separation costs. Further investigation of inventory build and receivables timing is warranted before treating the current cash position of roughly $451 million as a reliable measure of standalone liquidity.

Download Financial Ratios Data

Includes 30+ ratios · 5 years · Updated daily

Consensus & Technical Research Suite
Open SOLV Terminal

SOLV Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

SOLV — Frequently Asked Questions

Quick answers to the most common questions about buying SOLV stock.

What is Solventum Corporation's P/E ratio?

Solventum Corporation's current P/E ratio is 99.0x. The historical average is 16.4x. This places it at the 100th percentile of its historical range.

What is Solventum Corporation's EV/EBITDA?

Solventum Corporation's current EV/EBITDA is 8.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.3x.

What is Solventum Corporation's ROE?

Solventum Corporation's return on equity (ROE) is 38.9%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 16.1%.

Is SOLV stock overvalued?

Based on historical data, Solventum Corporation is trading at a P/E of 99.0x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are Solventum Corporation's profit margins?

Solventum Corporation has 53.5% gross margin and 26.2% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.

How much debt does Solventum Corporation have?

Solventum Corporation's Debt/EBITDA ratio is 1.9x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.